We are live on
!
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.15B
Turnover
18.82%
1-Year Est. Return
43.46%
This Fund
S&P 500
This Quarter
Est. Return
-0.76%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$307M
AUM Growth
+$31.9M
(+12%)
Cap. Flow
+$40.1M
Cap. Flow
% of AUM
13.06%
Top 10 Holdings %
Top 10 Hldgs %
24.74%
Holding
140
New
26
Increased
30
Reduced
34
Closed
7
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
+$9.59M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$6.03M |
| 3 |
GE Aerospace
GE
|
+$5.63M |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.15M |
| 5 |
Comcast
CMCSA
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$4.53M |
| 2 |
MacroGenics
MGNX
|
+$1.86M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$1.43M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$1.26M |
| 5 |
EOG Resources
EOG
|
+$1.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.28% |
| 2 | Communication Services | 20.72% |
| 3 | Energy | 14.2% |
| 4 | Industrials | 11.62% |
| 5 | Technology | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Parker-Hannifin
PH
$122B
| $434K | 0.14% |
3,727
| – | – |
2013 Q2
8 quarters
|
|
102
DELISTED
Liberty Broadband Class A
LBRDA
| $421K | 0.14% |
8,259
+864
| +12% | +$46K |
2014 Q4
2 quarters
|
|
|
ENDP
103
DELISTED
Endo International plc
ENDP
| $418K | 0.14% |
+5,250
| New | +$453K |
2015 Q2
0 quarters
|
|
104
State Street SPDR S&P 500 ETF Trust
SPY
$808B
| $396K | 0.13% |
+1,925
| New | +$405K |
2015 Q2
0 quarters
|
|
|
MDSO
105
DELISTED
Medidata Solutions, Inc.
MDSO
| $386K | 0.13% |
7,100
+400
| +6% | +$21.5K |
2013 Q3
7 quarters
|
|
106
Netflix
NFLX
$294B
| $361K | 0.12% |
38,500
+3,500
| +10% | +$29.3K |
2015 Q1
1 quarter
|
|
|
SIOX
107
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $346K | 0.11% |
+2,125
| New | +$360K |
2015 Q2
0 quarters
|
|
|
LLL
108
DELISTED
L3 Technologies, Inc.
LLL
| $340K | 0.11% |
3,000
| – | – |
2013 Q2
8 quarters
|
|
109
Puma Biotechnology
PBYI
$513M
| $336K | 0.11% |
+2,875
| New | +$521K |
2015 Q2
0 quarters
|
|
110
IBM
IBM
$218B
| $333K | 0.11% |
2,144
| – | – |
2013 Q2
8 quarters
|
|
111
Procter & Gamble
PG
$369B
| $313K | 0.1% |
4,000
| – | – |
2013 Q2
8 quarters
|
|
112
Walmart Inc
WMT
$944B
| $309K | 0.1% |
13,065
| – | – |
2013 Q2
8 quarters
|
|
113
Goldman Sachs
GS
$257B
| $298K | 0.1% |
1,425
| – | – |
2013 Q2
8 quarters
|
|
114
State Street Health Care Select Sector SPDR ETF
XLV
$45.8B
| $298K | 0.1% |
4,000
| – | – |
2013 Q3
7 quarters
|
|
115
Tvardi Therapeutics
TVRD
$13.3M
| $287K | 0.09% |
+656
| New | +$254K |
2015 Q2
0 quarters
|
|
116
Consolidated Edison
ED
$41.4B
| $252K | 0.08% |
4,350
| – | – |
2013 Q2
8 quarters
|
|
117
DELISTED
Hess
HES
| $241K | 0.08% |
3,600
| – | – |
2013 Q2
8 quarters
|
|
118
Berkshire Hathaway Class B
BRK.B
$1.13T
| $211K | 0.07% |
1,550
| – | – |
2014 Q3
3 quarters
|
|
119
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
| $83K | 0.03% |
72,341
| – | – |
2014 Q4
2 quarters
|
|
120
Philip Morris
PM
$319B
| – | – |
-14,090
| Closed | -$1.06M | – |
|
121
SiriusXM
SIRI
$9.11B
| – | – |
-21,197
| Closed | -$810K | – |
|
|
TWTR
122
DELISTED
Twitter, Inc.
TWTR
| – | – |
-28,508
| Closed | -$1.43M | – |
|
|
MON
123
DELISTED
Monsanto Co
MON
| – | – |
-3,755
| Closed | -$423K | – |
|
124
DELISTED
Du Pont De Nemours E I
DD
| – | – |
-3,054
| Closed | -$207K | – |
|
Similar funds
WB
AIC
CFP
HT
AA
CIG
CIS
FWM
Private Capital Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, Private Capital Advisors held 140 positions worth $307M, up 12% from $275M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Private Capital Advisors deployed $40.1M of net new capital in Q2 2015, opening 26 new positions and adding to 30 existing holdings. Its largest new stake was Thermo Fisher Scientific: 46,230 shares worth $6M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $4.53M trimmed.
- Private Capital Advisors's largest Q2 2015 buy was Thermo Fisher Scientific: 46,230 shares worth $6M.
- Private Capital Advisors added most to Trillium Therapeutics Inc. in Q2 2015, an estimated $9.59M increase.
- Private Capital Advisors's biggest Q2 2015 reduction was Ionis Pharmaceuticals, cutting an estimated $4.53M.
- Private Capital Advisors fully exited Twitter, Inc. in Q2 2015, selling an estimated $1.43M.
- Private Capital Advisors's ten largest holdings make up 25% of its $307M portfolio in Q2 2015.
- Private Capital Advisors opened 26 new positions and closed 7 in Q2 2015.
- Private Capital Advisors's portfolio value rose 12% quarter-over-quarter to $307M.
Based on Private Capital Advisors's 13F filing for Q2 2015, filed 6 Aug 2015.